Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally. The company offers maleic anhydride, fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L (+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, medical intermediaries, pharmaceutical adjuvant, active pharmaceutical ingredients, etc. It is also involved in the research and development of medicine and nutraceutical products; manufacture, sale, and trading of organic acid products; general trading; and property holding activities. Changmao Biochemical Engineering Company Limited was founded in 1992 and is headquartered in Changzhou, China.
Research context
Changmao Biochemical Engineering Company Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Changmao Biochemical Engineering Company Limited is currently in a long term uptrend where the price is trading 9.2% above its 200 day moving average.
From a valuation standpoint, the stock is 49.8% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.7.
Changmao Biochemical Engineering Company Limited's total revenue rose by 11.8% to $220M since the same quarter in the previous year.
Its net income has dropped by 3.8% to $15M since the same quarter in the previous year.
Finally, its free cash flow grew by 206.2% to $15M since the same quarter in the previous year.
Based on the above factors, Changmao Biochemical Engineering Company Limited gets an overall score of 4/5.